The main objective of this study was to investigate the causal relationship between smoking and depression/ anxiety, and specially the direction of this relationship, in order to analyze the link between the degree of...The main objective of this study was to investigate the causal relationship between smoking and depression/ anxiety, and specially the direction of this relationship, in order to analyze the link between the degree of dependence to nicotine, and the anxio-depressive levels, according to HADS test and the Fagerstrom test of nicotine dependence. Our study included 647 smokers and 400 non-smoking male. To facilitate this study, we distributed questionnaires to several private GP surgeries, to be completed by patients. In this study, we found that there is a close relationship between the level of nicotine addiction, anxiety levels and the emergence of depressive disorders. A highly depressive state implies a very strong addiction to tobacco;a high percentage of subjects showed little or no tobacco dependence. When anxiety appears (even when non-significant) dependence increases from medium to high, and very high, whereas in the absence of depression, 80% to 90% of patients show no tobacco addiction. The addiction to tobacco increases at the beginning of depression and reach her maximum in depressed patients. Thus, the anxiolytic effect of nicotine becomes an anxiogenic effect in anxious subjects, when subjects move from non-dependence to medium and very strong addiction.展开更多
Background: The prevalence of carpal tunnel syndrome (CTS) and of anxiety and depression in primary care practice are high. Different studies had shown an increased prevalence of anxiety and depression in CTS patients...Background: The prevalence of carpal tunnel syndrome (CTS) and of anxiety and depression in primary care practice are high. Different studies had shown an increased prevalence of anxiety and depression in CTS patients. Nevertheless, few papers had been published studying the anxiety and depression scales in the treatment of CTS, either with corticosteroid injections (I) or with surgical decompression (S). Objective: To assess whether clinical improvement observed after the treatment of CTS either with I or with S correlates with an improvement in the punctuations of the Hospital Anxiety and Depression scales (HADS), at 3, 6 and 12-month follow-up. Methods: Randomized and open-label clinical trial, comparing I and S. Patients with symptoms suggestive of CTS (nocturnal paraesthesias) of at least 3 months duration and neurophysiological confirmation were included. Patients with clinically apparent motor impairment were excluded. The subjective evaluation of symptoms was carried out using the visual-analogue scale of pain (VAS-p). Clinical reviews were performed 3, 6 and 12 months after treatment. Each patient completed the HADS questionnaire and a VAS-p at 0, 3, 6, and 12 months. Statistical significance was established using the Student’s t test and the Mann-Whitney U test when necessary. A linear regression analysis was used to know the effect of the treatment adjusted for the initial score of both scales. Results: 65 patients were included (30 in group I and 35 in group S). There was no statistical difference between both groups in terms of age, gender distribution, disease duration, VAS-p, neurophysiological testing severity of CTS or the 8 subscales of HADS. Both groups improved significantly in relation to the baseline VAS-p values, in the reviews at 3, 6 and 12 months, with no significant differences between I and S. At 6 months, the reduction in the anxiety scale was around 3 points for both treatments (S = 3.6 and I = 3.2), without reaching significant differences. At 12 months, it was somewhat higher for those treated with I, but always around 3 points and without significant differences. The Depression scale score was slightly reduced at 6 months, and in a similar way for both groups (I = 1 and S = 1.19;p = 0.8). After 12 months, group I doubled the previous reduction, with group S experiencing a very slight change (I = 1.96 and S = 1.03;p = 0.3). When analysing the effect of group S on group I, the result was a reduction of 0.25 points for Anxiety (p = 0.7) and of 0.02 points for Depression (p = 0.9). Conclusions: Treatment of CTS with I or S results in a similar and discrete improvement in Anxiety scores on the HADS scale at 6 and 12 months. For both types of treatment, the Depression scores barely changed at 6 months, being somewhat higher in group I after 12-month follow-up. The independent effect of the S on both scales is small and not significant.展开更多
BACKGROUND Psychological assessment after intensive care unit(ICU)discharge is increasingly used to assess patients'cognitive and psychological well-being.However,few studies have examined those who recovered from...BACKGROUND Psychological assessment after intensive care unit(ICU)discharge is increasingly used to assess patients'cognitive and psychological well-being.However,few studies have examined those who recovered from coronavirus disease 2019(COVID-19).There is a paucity of data from the Middle East assessing the post-ICU discharge mental health status of patients who had COVID-19.AIM To evaluate anxiety and depression among patients who had severe COVID-19.METHODS This is a prospective single-center follow-up questionnaire-based study of adults who were admitted to the ICU or under ICU consultation for>24 h for COVID-19.Eligible patients were contacted via telephone.The patient’s anxiety and depression six months after ICU discharge were assessed using the Hospital Anxiety and Depression Scale(HADS).The primary outcome was the mean HADS score.The secondary outcomes were risk factors of anxiety and/or depression.RESULTS Patients who were admitted to the ICU because of COVID-19 were screened(n=518).Of these,48 completed the questionnaires.The mean age was 56.3±17.2 years.Thirty patients(62.5%)were male.The main comorbidities were endocrine(n=24,50%)and cardiovascular(n=21,43.8%)diseases.The mean overall HADS score for anxiety and depression at 6 months post-ICU discharge was 11.4(SD±8.5).A HADS score of>7 for anxiety and depression was detected in 15 patients(30%)and 18 patients(36%),respectively.Results from the multivariable ordered logistic regression demonstrated that vasopressor use was associated with the development of anxiety and depression[odds ratio(OR)39.06,95% confidence interval:1.309-1165.8;P<0.05].CONCLUSION Six months after ICU discharge,30% of patients who had COVID-19 demonstrated a HADS score that confirmed anxiety and depression.To compare the psychological status of patients following an ICU admission(with vs without COVID-19),further studies are warranted.展开更多
目的:评价原发性开角型青光眼(primary open angle glaucoma,POAG)患者的心理和生活质量状况并分析其影响因素。方法:采用前瞻性临床对照的方法,对60例POAG患者分别采用青光眼生活质量-15中文版(Glaucoma Quality of Life-15,GQL-15)和...目的:评价原发性开角型青光眼(primary open angle glaucoma,POAG)患者的心理和生活质量状况并分析其影响因素。方法:采用前瞻性临床对照的方法,对60例POAG患者分别采用青光眼生活质量-15中文版(Glaucoma Quality of Life-15,GQL-15)和综合医院焦虑抑郁量表(Hospital Anxiety and Depression Scale,HADS)中文版评定患者最近1mo的生活质量和焦虑、抑郁状况,给予降压药物干预后1mo再次进行评定。60例健康自愿者作为对照,分析其心理和生活质量变化情况。结果:POAG患者焦虑、抑郁及共患患者发生率分别为33.3%,26.7%,13.4%。患者抑郁焦虑评分及GQL评分与病程、眼压、年龄、药物种类和价格成正相关(P<0.05),与平均月收入、视力成负相关(P<0.05)。通过降压药物干预,患者焦虑、抑郁评分及生活质量评分明显好转(F焦虑评分=9.54,F抑郁评分=6.88,FGQL评分=8.82;P<0.05)。结论:POAG患者焦虑、抑郁状况加重,生活质量明显降低。患者抑郁焦虑评分及生活质量评分与病程、年龄、平均月收入、药物种类、药物价格、视力、眼压、视野等方面紧密相关。降压药物干预有助于青光眼患者生活质量和心理逐步康复。展开更多
目的通过观察施用风险预警方法对高龄患者行无痛胃肠镜的护理,研究其可行性。方法从2018年10月—2019年10月期间在医院行无痛肠胃镜的高龄患者中抽取104例,随机分为预警组和常规组,每组52例。常规组施行无痛胃肠镜的日常护理,预警组施...目的通过观察施用风险预警方法对高龄患者行无痛胃肠镜的护理,研究其可行性。方法从2018年10月—2019年10月期间在医院行无痛肠胃镜的高龄患者中抽取104例,随机分为预警组和常规组,每组52例。常规组施行无痛胃肠镜的日常护理,预警组施行无痛胃肠镜的风险预警护理,观察两组的情绪量表(hospital anxiety and depression scale,HADS)评分和并发症发生率。结果对两组患者的术前情绪进行测量,并对比两组的麻醉药剂用量和术中内镜使用时间、呼吸抑制发生率,发现预警组数据表示出的护理结果均优于常规组。预警组抑郁和焦虑评分明显低于常规组。而在术后预警值在呛咳和咽部不适的发生率明显低于常规组,差异有统计学意义(P<0.05)。其他并发症类型两组比较差异无统计学意义(P>0.05)。结论对高龄患者行无痛胃肠镜时,做好风险预警护理能够明显缩短患者治疗期,缓解患者的焦虑心理,降低术后并发症的发生率。展开更多
文摘The main objective of this study was to investigate the causal relationship between smoking and depression/ anxiety, and specially the direction of this relationship, in order to analyze the link between the degree of dependence to nicotine, and the anxio-depressive levels, according to HADS test and the Fagerstrom test of nicotine dependence. Our study included 647 smokers and 400 non-smoking male. To facilitate this study, we distributed questionnaires to several private GP surgeries, to be completed by patients. In this study, we found that there is a close relationship between the level of nicotine addiction, anxiety levels and the emergence of depressive disorders. A highly depressive state implies a very strong addiction to tobacco;a high percentage of subjects showed little or no tobacco dependence. When anxiety appears (even when non-significant) dependence increases from medium to high, and very high, whereas in the absence of depression, 80% to 90% of patients show no tobacco addiction. The addiction to tobacco increases at the beginning of depression and reach her maximum in depressed patients. Thus, the anxiolytic effect of nicotine becomes an anxiogenic effect in anxious subjects, when subjects move from non-dependence to medium and very strong addiction.
文摘Background: The prevalence of carpal tunnel syndrome (CTS) and of anxiety and depression in primary care practice are high. Different studies had shown an increased prevalence of anxiety and depression in CTS patients. Nevertheless, few papers had been published studying the anxiety and depression scales in the treatment of CTS, either with corticosteroid injections (I) or with surgical decompression (S). Objective: To assess whether clinical improvement observed after the treatment of CTS either with I or with S correlates with an improvement in the punctuations of the Hospital Anxiety and Depression scales (HADS), at 3, 6 and 12-month follow-up. Methods: Randomized and open-label clinical trial, comparing I and S. Patients with symptoms suggestive of CTS (nocturnal paraesthesias) of at least 3 months duration and neurophysiological confirmation were included. Patients with clinically apparent motor impairment were excluded. The subjective evaluation of symptoms was carried out using the visual-analogue scale of pain (VAS-p). Clinical reviews were performed 3, 6 and 12 months after treatment. Each patient completed the HADS questionnaire and a VAS-p at 0, 3, 6, and 12 months. Statistical significance was established using the Student’s t test and the Mann-Whitney U test when necessary. A linear regression analysis was used to know the effect of the treatment adjusted for the initial score of both scales. Results: 65 patients were included (30 in group I and 35 in group S). There was no statistical difference between both groups in terms of age, gender distribution, disease duration, VAS-p, neurophysiological testing severity of CTS or the 8 subscales of HADS. Both groups improved significantly in relation to the baseline VAS-p values, in the reviews at 3, 6 and 12 months, with no significant differences between I and S. At 6 months, the reduction in the anxiety scale was around 3 points for both treatments (S = 3.6 and I = 3.2), without reaching significant differences. At 12 months, it was somewhat higher for those treated with I, but always around 3 points and without significant differences. The Depression scale score was slightly reduced at 6 months, and in a similar way for both groups (I = 1 and S = 1.19;p = 0.8). After 12 months, group I doubled the previous reduction, with group S experiencing a very slight change (I = 1.96 and S = 1.03;p = 0.3). When analysing the effect of group S on group I, the result was a reduction of 0.25 points for Anxiety (p = 0.7) and of 0.02 points for Depression (p = 0.9). Conclusions: Treatment of CTS with I or S results in a similar and discrete improvement in Anxiety scores on the HADS scale at 6 and 12 months. For both types of treatment, the Depression scores barely changed at 6 months, being somewhat higher in group I after 12-month follow-up. The independent effect of the S on both scales is small and not significant.
基金the Researchers Supporting Project number,King Saud University,Riyadh,Saudi Arabia,No.RSPD2024R919.
文摘BACKGROUND Psychological assessment after intensive care unit(ICU)discharge is increasingly used to assess patients'cognitive and psychological well-being.However,few studies have examined those who recovered from coronavirus disease 2019(COVID-19).There is a paucity of data from the Middle East assessing the post-ICU discharge mental health status of patients who had COVID-19.AIM To evaluate anxiety and depression among patients who had severe COVID-19.METHODS This is a prospective single-center follow-up questionnaire-based study of adults who were admitted to the ICU or under ICU consultation for>24 h for COVID-19.Eligible patients were contacted via telephone.The patient’s anxiety and depression six months after ICU discharge were assessed using the Hospital Anxiety and Depression Scale(HADS).The primary outcome was the mean HADS score.The secondary outcomes were risk factors of anxiety and/or depression.RESULTS Patients who were admitted to the ICU because of COVID-19 were screened(n=518).Of these,48 completed the questionnaires.The mean age was 56.3±17.2 years.Thirty patients(62.5%)were male.The main comorbidities were endocrine(n=24,50%)and cardiovascular(n=21,43.8%)diseases.The mean overall HADS score for anxiety and depression at 6 months post-ICU discharge was 11.4(SD±8.5).A HADS score of>7 for anxiety and depression was detected in 15 patients(30%)and 18 patients(36%),respectively.Results from the multivariable ordered logistic regression demonstrated that vasopressor use was associated with the development of anxiety and depression[odds ratio(OR)39.06,95% confidence interval:1.309-1165.8;P<0.05].CONCLUSION Six months after ICU discharge,30% of patients who had COVID-19 demonstrated a HADS score that confirmed anxiety and depression.To compare the psychological status of patients following an ICU admission(with vs without COVID-19),further studies are warranted.
文摘目的研究原发性干燥综合征(primary Sjgren's syndrome,p SS)患者生活质量及焦虑抑郁情况并分析其影响因素。方法筛选309例p SS患者(男性5例,女性304例)作为研究对象,应用健康状况调查问卷(SF-36)评估患者生活质量,医院焦虑抑郁量表(HADS)评估患者焦虑抑郁情况。结果 p SS患者的SF-36各维度积分明显低于普通人群,HADS量表焦虑评分(HAS)、抑郁评分(HDS)均高于内科就诊人群(女性患者)(P<0.05)。进一步对女性p SS患者分析显示,疼痛评分、疲劳乏力评分与SF-36生理健康领域得分下降有关;疲劳乏力评分与心理健康领域得分下降有关。疼痛评分、疲劳乏力评分与HAS和HDS评分升高均有关。年龄的增长与HAS评分下降有关,皮肤干燥评分与HDS评分升高有关。结论 p SS患者的生活质量较普通人群明显下降,且具有明显的焦虑抑郁情绪。疼痛、疲劳乏力是影响生活质量和焦虑抑郁情绪的主要因素。
文摘目的:评价原发性开角型青光眼(primary open angle glaucoma,POAG)患者的心理和生活质量状况并分析其影响因素。方法:采用前瞻性临床对照的方法,对60例POAG患者分别采用青光眼生活质量-15中文版(Glaucoma Quality of Life-15,GQL-15)和综合医院焦虑抑郁量表(Hospital Anxiety and Depression Scale,HADS)中文版评定患者最近1mo的生活质量和焦虑、抑郁状况,给予降压药物干预后1mo再次进行评定。60例健康自愿者作为对照,分析其心理和生活质量变化情况。结果:POAG患者焦虑、抑郁及共患患者发生率分别为33.3%,26.7%,13.4%。患者抑郁焦虑评分及GQL评分与病程、眼压、年龄、药物种类和价格成正相关(P<0.05),与平均月收入、视力成负相关(P<0.05)。通过降压药物干预,患者焦虑、抑郁评分及生活质量评分明显好转(F焦虑评分=9.54,F抑郁评分=6.88,FGQL评分=8.82;P<0.05)。结论:POAG患者焦虑、抑郁状况加重,生活质量明显降低。患者抑郁焦虑评分及生活质量评分与病程、年龄、平均月收入、药物种类、药物价格、视力、眼压、视野等方面紧密相关。降压药物干预有助于青光眼患者生活质量和心理逐步康复。
文摘目的通过观察施用风险预警方法对高龄患者行无痛胃肠镜的护理,研究其可行性。方法从2018年10月—2019年10月期间在医院行无痛肠胃镜的高龄患者中抽取104例,随机分为预警组和常规组,每组52例。常规组施行无痛胃肠镜的日常护理,预警组施行无痛胃肠镜的风险预警护理,观察两组的情绪量表(hospital anxiety and depression scale,HADS)评分和并发症发生率。结果对两组患者的术前情绪进行测量,并对比两组的麻醉药剂用量和术中内镜使用时间、呼吸抑制发生率,发现预警组数据表示出的护理结果均优于常规组。预警组抑郁和焦虑评分明显低于常规组。而在术后预警值在呛咳和咽部不适的发生率明显低于常规组,差异有统计学意义(P<0.05)。其他并发症类型两组比较差异无统计学意义(P>0.05)。结论对高龄患者行无痛胃肠镜时,做好风险预警护理能够明显缩短患者治疗期,缓解患者的焦虑心理,降低术后并发症的发生率。
